HLA-B and Epstein-Barr virus infection: Furthermore, no evident difference in clinical outcome within the first year after transplantation was found between EBV seropositive HLA-B8+ patients receiving HLA-B*44:02+ vs. HLA-B*44:03+ allografts in the absence of an active EBV infection.